Correlation of histopathologic characteristics to protein expression and function in malignant melanoma

• Charlotte Welinder,

  Affiliations Division of Oncology and Pathology, Dept. of Clinical Sciences Lund, Lund University, Lund, Sweden, Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden

  http://orcid.org/0000-0001-9626-0576

  ⨯
• Krzysztof Pawłowski,

  Affiliations Faculty of Agriculture and Biology, Dept. of Experimental Design and Bioinformatics, Warsaw University of Life Sciences, Warszawa, Poland, Dept. of Translational Medicine, Lund University, Malmö, Sweden

  ⨯
• A. Marcell Szasz,

  Affiliations Division of Oncology and Pathology, Dept. of Clinical Sciences Lund, Lund University, Lund, Sweden, Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden, 2nd Dept. of Pathology, Semmelweis University, Budapest, Hungary

  ⨯
• Maria Yakovleva,

  Affiliation Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden

  ⨯
• Yutaka Sugihara,

  Affiliation Division of Oncology and Pathology, Dept. of Clinical Sciences Lund, Lund University, Lund, Sweden

  ⨯
• Johan Malm,

  Affiliations Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden, Dept. of Translational Medicine, Lund University, Malmö, Sweden

  ⨯
• Göran Jönsson,

  Affiliation Division of Oncology and Pathology, Dept. of Clinical Sciences Lund, Lund University, Lund, Sweden

  ⨯
• Christian Ingvar,

  Affiliation Dept. of Surgery, Dept. of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden

  ⨯
• Lotta Lundgren,

  Affiliations Division of Oncology and Pathology, Dept. of Clinical Sciences Lund, Lund University, Lund, Sweden, Dept. of Oncology, Skåne University Hospital, Lund, Sweden

  ⨯
• Bo Baldetorp,

  Affiliation Division of Oncology and Pathology, Dept. of Clinical Sciences Lund, Lund University, Lund, Sweden

  ⨯
• Håkan Olsson,

  Affiliations Division of Oncology and Pathology, Dept. of Clinical Sciences Lund, Lund University, Lund, Sweden, Dept. of Oncology, Skåne University Hospital, Lund, Sweden, Cancer Epidemiology, Dept. of Clinical Sciences, Lund University, Lund, Sweden

  ⨯
• Melinda Rezeli,

  Affiliation Clinical Protein Science & Imaging, Biomedical Centre, Dept. of Biomedical Engineering, Lund University, BMC D13, Lund, Sweden

  ⨯
• Thomas Laurell,

  Affiliations Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden, Clinical Protein Science & Imaging, Biomedical Centre, Dept. of Biomedical Engineering, Lund University, BMC D13, Lund, Sweden

  ⨯
• Elisabet Wieslander,

  Affiliation Division of Oncology and Pathology, Dept. of Clinical Sciences Lund, Lund University, Lund, Sweden

  ⨯
• György Marko-Varga

  * E-mail: Gyorgy.Marko-Varga@bme.lth.se

  Affiliations Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden, Clinical Protein Science & Imaging, Biomedical Centre, Dept. of Biomedical Engineering, Lund University, BMC D13, Lund, Sweden, First Dept. of Surgery, Tokyo Medical University, Tokyo, Japan

  ⨯